Skip to content

Finding solutions to thrive after birth asphyxia in Africa: An open-label dose-finding clinical trial (Phase Ib study) - SANE-Uganda

Finding solutions to thrive after birth asphyxia in Africa: An open-label dose-finding clinical trial (Phase Ib study) - SANE-Uganda

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
PACTR
Registry ID
PACTR202202647130754
Enrollment
30
Registered
2022-02-11
Start date
2022-03-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal Diseases

Interventions

Sildenafil

Sponsors

Research Institute of the McGill University Health Centre
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - Male and female neonates meeting the criteria for birth asphyxia: - Gestational age = 36 weeks and birth weight = 1800 g; - Admitted to Kawempe Hospital or Nsambya Hospital within 48 hours of life; - Need for continued resuscitation after birth and/or 5-minute Apgar score =5; - Evidence of neonatal encephalopathy by an abnormal neurological exam (modified Sarnat score of 2-3 or abnormal aEEG).

Exclusion criteria

Exclusion criteria: - Absent heart rate at 10 minutes/imminent death - Neonates with major congenital malformations - Neonates with grade 3 AKI (serum creatinine rise =3x lowest previous creatinine or creatinine > 2.5 mg/dL = 221 mcmol/L or receipt of dialysis) - Neonates with intraventricular and/or intraparenchymal hemorrhage on cranial ultrasound (cUS) performed on day 1-2 of life - Mother living permanently outside 20km radius of Kawempe Hospital or Nsambya Hospital - Neonates whose parents are unwilling or unable to give informed written consent to enter the study

Design outcomes

Primary

MeasureTime frame
Maximum tolerable dose

Secondary

MeasureTime frame
Sildenafil safety;Sildenafil pharmacokinetics and pharmacodynamics

Countries

Uganda

Contacts

Public ContactPia Wintermark

Associate Professor of Pediatrics

pia.wintermark@mcgill.ca+15144124452

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026